Literature DB >> 3669764

Saturation index of blood cell membrane fatty acids before and after IFN treatment in hairy cell leukemia.

C P Worman1, W R Barker, K Apostolov.   

Abstract

Cells from the peripheral blood of 32 patients with hairy cell leukemia (HCL) were analyzed for cell membrane fatty acid composition. A consistent and significant change was found in the relative amounts of stearic and oleic acid components, which is expressed as the saturation index (SI), the ratio of stearic to oleic acid content. In all patients, SI was reduced in the erythrocytes, leukocytes, and platelets. On extended treatment with interferon, the hematological improvement was accompanied by an increase in SI. In two patients, one deteriorating after cessation of treatment and the other on a low maintenance dose of interferon, concurrent influenza infection induced temporary improvements in the blood cell counts, as well as increase in SI values. These results indicate that endogenous interferon can also be effective in inducing hematological and SI improvement in this disease. The relevance of low SI values and concomitant increase in membrane fluidity to the malignant transformation is discussed. It is proposed that one effect of interferon is to reduce the production of growth factors by reducing the malignant cell mass.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3669764

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  3 in total

Review 1.  The potential of interferons in malignant disease.

Authors:  K Okita; T Kaneko
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

2.  Natural IFN-alpha therapy in hairy-cell leukaemia (namalva-type IFN--Wellferon).

Authors:  C P Worman; A B Nethersell; J M Bottomley; K Apostolov; W Barker; J C Cawley
Journal:  Klin Wochenschr       Date:  1987-07-15

3.  Stearic acid and carcinogenesis.

Authors:  N A Habib; C B Wood; K Apostolov; W Barker; M J Hershman; M Aslam; D Heinemann; B Fermor; R C Williamson; W E Jenkins
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.